
Timothy Adams
@Timadams2023
Followers
100
Following
318
Media
0
Statuses
91
Current Chair @MoffittNews Institute Board | Former President, Time Customer Service, Inc| Helping guide Moffitt’s mission and strategy. Thoughts are my own.
Joined March 2023
This is outstanding research. The pace of change in our understanding of cancer is so encouraging. I just read that globally there are 50,000 clinical trials underway currently. We are going to ultimately outsmart cancer.
Moffitt Study Uncovers New Mechanism of Immunotherapy Resistance | Moffitt Exciting research from the Tsai lab published in Nature!.
0
0
3
RT @LungCancerEu: New update from SOLACE: Ireland’s GP‑led #lungcancer screening pilot is getting positive early feedback. 📍 Mobile low‑dos….
0
11
0
RT @WiltonSimpson: The nursing shortage caused in large part by an aging population and COVID required strategic planning and the thoughtfu….
0
4
0
Richard and his family have impacted Tampa in a profoundly positive way for a century. He has helped Moffitt for decades. So excited to see them touring to learn about our research on “food as medicine “.
Wonderful to host Richard Gonzmart and Andrea Gonzmart Williams of @Columbia1905 @MoffittNews today! We toured the PEARL Research Kitchen (delicious keto breakfast included 🍳), Daniel Abate-Daga’s Lab & the Hwu #Immunology Lab. The Gonzmart family are generous supporters of
0
0
7
Just like your trademark “engineering the end of cancer” truly extraordinary!!.
Excited to share a glimpse into the future of cancer modeling at @MoffittNews. This 3D patient-derived microtumor, developed as a “Patient Avatar” for ovarian cancer research, was cultured for 14 days under continuous perfusion, preserving its microenvironment and cellular
0
0
7
RT @OncNewsCentral: @DrBlueMD at #ASCO25: Trispecifics could be a game-changer in #MultipleMyeloma. “The more targets you hit on the plasma….
oncologynewscentral.com
First-in-human trials of trispecific treatments for multiple myeloma and long-term data on CAR-T use are among the highlights at ASCO 2025, says Brandon Blue, MD.
0
4
0
It is so cool to have living legends like Dr Mule living right here in Tampa.
Hard to believe now, but there was a time when most thought the immune system couldn’t really be used to fight #cancer. In this episode of #TheImmunoVerse podcast, Dr. Jim Mule (@DrJamesMule) shares how that mindset shifted and how he helped lead the charge. 🎧 Listen now at
1
1
11
A very large step as you continue to build a magnificent “Manhattan Project” team for the war on cancer. So many talented people from so many disciplines all being assembled in one place. Let’s Go!!!.
We’re thrilled to welcome Ignacio Wistuba, MD, as Chair of our new Translational Pathology Department @MoffittNews! Learn more about the department and how it will improve patient outcomes and advance clinical research.
0
1
4
Rep Bilirakis has been in the trenches with us for more than a decade. Speros is the place where the difference will finally be made. A place where people from all professions and experiences will join forces to win the fight. So great to have Rep Bilirakis in the fight.
Congressman @RepGusBilirakis visited our #SperosFL campus to get a firsthand look at the groundbreaking biotech innovation and collaborative research driving the future of cancer care.
0
1
8
RT @MoffittGR: Congressman @RepGusBilirakis visited our #SperosFL campus to get a firsthand look at the groundbreaking biotech innovation a….
0
3
0
Excited for the world to hear about the breakthroughs to come due to the incredible team science at Moffitt.
Moffitt is thrilled to be at #ASCO25! At this year’s meeting, our experts are sharing breakthroughs in immunotherapy, artificial intelligence, radiation therapy, triplet therapy and more. Stop by booth 13018 to meet our experts and see how we’re advancing cancer research.
0
0
7
Rep Buchanan is an absolute Jedi in the fight against cancer. Thank you so much for all you do.
It was great meeting with @PatrickHwuMD and @MoffittNews leadership to discuss strengthening Medicare programs. We must ensure these programs continue to provide world-class cancer care for patients in Florida and across the country.
0
0
3
Clinical trials are how we ultimately kill the beast. A tremendous partnership between researchers, clinicians, and most importantly patients to find new more promising therapies and interventions.
On #ClinicalTrialsDay, we celebrate Moffitt’s exceptional clinical research team and their vital role in advancing cancer care. Every breakthrough treatment we have today is built on the results of past clinical trials and the dedication of researchers who make them possible.
0
0
5
Moffitt nurses are easy to describe. EXTRAORDINARY!!.
Nursing week recap: Last week, we celebrated the resilience, compassion and dedication Moffitt nurses show every day. Our nurses are the best of the best and a joy to work with and lead. Thank you for all that you do! 💙 #NursesWeek #MoffittNurses
0
0
5
Fantastic. So looking forward to the cures that will come from these labs.
At the Lab Design Conference in Denver presenting the Moffitt Discovery and Innovation Center at SPEROS FL with my colleagues at DLR group/TKD. Thrilled to showcase our innovative design - Hope 3 ways - showcasing the integration of cancer biology, drug discovery, and
1
1
7
RT @MiliUPetrovic: The beam that will soon be hoisted to the top of the Moffitt Discovery and Innovation Center at Speros represents more t….
0
4
0
So well said Dr. Cleveland. The state of Florida has been committed to battling cancer for decades. This consistent support is enormously helpful and very much appreciated.
Today Dr. John Cleveland, the EVP, Center Director, and Chief Science Officer, spoke before the Florida Senate Health Policy committee in favor of PCB 7028, and expanding the State’s investment into cancer research.
0
1
12